Advertisement

PLOS ONE

  • Publish
    • Submissions
      • Getting Started
      • Submission Guidelines
      • Figures
      • Tables
      • Supporting Information
      • LaTeX
      • What We Publish
      • Preprints
      • Revising Your Manuscript
      • Submit Now
      • Calls for Papers
    • Policies
      • Best Practices in Research Reporting
      • Human Subjects Research
      • Animal Research
      • Competing Interests
      • Disclosure of Funding Sources
      • Licenses and Copyright
      • Data Availability
      • Complementary Research
      • Materials, Software and Code Sharing
      • Ethical Publishing Practice
      • Authorship
      • Corrections, Expressions of Concern, and Retractions
    • Manuscript Review and Publication
      • Criteria for Publication
      • Editorial and Peer Review Process
      • Editor Center
      • Resources for Editors
      • Guidelines for Reviewers
      • Accepted Manuscripts
      • Comments

    Submit Your Manuscript

    Discover a faster, simpler path to publishing in a high-quality journal. PLOS ONE promises fair, rigorous peer review, broad scope, and wide readership – a perfect fit for your research every time.

    Learn More Submit Now

  • About
    • Why Publish with PLOS ONE
    • Journal Information
    • Staff Editors
    • Editorial Board
    • Section Editors
    • Advisory Groups
    • Find and Read Articles
    • Publishing Information
    • Publication Fees
    • Press and Media
    • Contact
  • Browse
  • Search
    advanced search
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

  • Loading metrics

Open Access

Peer-reviewed

Research Article

Exploiting Clinical Trial Data Drastically Narrows the Window of Possible Solutions to the Problem of Clinical Adaptation of a Multiscale Cancer Model

  • Georgios S. Stamatakos ,

    * E-mail: gestam@central.ntua.gr

    Affiliation In Silico Oncology Group, Institute of Communication and Computer Systems, School of Electrical and Computer Engineering, National Technical University of Athens, Athens, Greece

    ⨯
  • Eleni C. Georgiadi,

    Affiliation In Silico Oncology Group, Institute of Communication and Computer Systems, School of Electrical and Computer Engineering, National Technical University of Athens, Athens, Greece

    ⨯
  • Norbert Graf,

    Affiliation Universität des Saarlandes, Klinik für Päd, Onkologie und Hämatologie, Homburg, Germany

    ⨯
  • Eleni A. Kolokotroni,

    Affiliation In Silico Oncology Group, Institute of Communication and Computer Systems, School of Electrical and Computer Engineering, National Technical University of Athens, Athens, Greece

    ⨯
  • Dimitra D. Dionysiou

    Affiliation In Silico Oncology Group, Institute of Communication and Computer Systems, School of Electrical and Computer Engineering, National Technical University of Athens, Athens, Greece

    ⨯

Exploiting Clinical Trial Data Drastically Narrows the Window of Possible Solutions to the Problem of Clinical Adaptation of a Multiscale Cancer Model

  • Georgios S. Stamatakos, 
  • Eleni C. Georgiadi, 
  • Norbert Graf, 
  • Eleni A. Kolokotroni, 
  • Dimitra D. Dionysiou
PLOS
x
  • Published: March 3, 2011
  • https://doi.org/10.1371/journal.pone.0017594
  • Article
  • Authors
  • Metrics
  • Comments
  • Media Coverage
Download PDF
 
  • Citation
  • XML
Print
  • Print article
  • Reprints
Share
  • RedditReddit
  • FacebookFacebook
  • LinkedInLinkedIn
  • MendeleyMendeley
  • TwitterTwitter
  • EmailEmail
  Check for updates via CrossMark
Advertisement

Subject Areas
?

For more information about PLOS Subject Areas, click here.

We want your feedback. Do these Subject Areas make sense for this article? Click the target next to the incorrect Subject Area and let us know. Thanks for your help!

  • Cancers and neoplasms  

    Is the Subject Area "Cancers and neoplasms" applicable to this article?

    Thanks for your feedback.

  • Renal cancer  

    Is the Subject Area "Renal cancer" applicable to this article?

    Thanks for your feedback.

  • Cell cycle and cell division  

    Is the Subject Area "Cell cycle and cell division" applicable to this article?

    Thanks for your feedback.

  • Apoptosis  

    Is the Subject Area "Apoptosis" applicable to this article?

    Thanks for your feedback.

  • Nephroblastoma  

    Is the Subject Area "Nephroblastoma" applicable to this article?

    Thanks for your feedback.

  • Malignant tumors  

    Is the Subject Area "Malignant tumors" applicable to this article?

    Thanks for your feedback.

  • Cancer treatment  

    Is the Subject Area "Cancer treatment" applicable to this article?

    Thanks for your feedback.

  • Cancer chemotherapy  

    Is the Subject Area "Cancer chemotherapy" applicable to this article?

    Thanks for your feedback.

  • Publications
  • PLOS Biology
  • PLOS Medicine
  • PLOS Computational Biology
  • PLOS Genetics
  • PLOS Pathogens
  • PLOS ONE
  • PLOS Neglected Tropical Diseases
  •  
  • PLOS Climate
  • PLOS Digital Health
  • PLOS Global Public Health
  • PLOS Sustainability and Transformation
  • PLOS Water
  • Home
  • Blogs
  • Collections
  • Give feedback
  • LOCKSS
  • Privacy Policy
  • Terms of Use
  • Advertise
  • Media Inquiries
  • Contact

PLOS PLOS is a nonprofit 501(c)(3) corporation, #C2354500, based in San Francisco, California, US